# Kinaset Therapeutics funding rounds and investors

As of 14 Oct 2026, Kinaset Therapeutics has raised $103M across 1 verified round on record; latest: $103 million Series B led by Forge Life Science Partners and RA Capital Management, announced 10 Jan 2026.

Developing inhaled therapeutics for respiratory diseases, specifically targeting severe asthma patients.

Website: https://kinasettherapeutics.com  
Page: https://fireround.dev/companies/kinasettherapeutics.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-01-10 | Series B | $103 million | Forge Life Science Partners, RA Capital Management | 5AM Ventures, Atlas Ventures, EQT Life Sciences, Gimv, Pictet Alternative Advisors, Schroders Capital, Sixty Degree Capital, Vivo Capital, Willett Advisors | [kinasettherapeutics.com](https://www.kinasettherapeutics.com/01-10-26-kinaset-therapeutics-announces-103-million-oversubscribed-series-b-financing), [businesswire.com](https://www.businesswire.com/news/home/20260110058494/en/Kinaset-Therapeutics-Announces-%24103-Million-Oversubscribed-Series-B-Financing-to-Advance-Novel-Inhaled-Therapeutic-Candidate-for-Respiratory-Diseases) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.